Showing 1841-1850 of 2494 results for "".
- Biotech Healthcare Announces Korean Good and Manufacturing Practices Approvalhttps://modernod.com/news/biotech-healthcare-announces-korean-good-and-manufacturing-practices-approval/2476544/Biotech Healthcare has received KGMP (Korean Goods & Manufacturing Practice) approval, allowing its ophthalmic products to be accessible to South Korean markets. “Today when we talk about addressing the urgent need of global eye care problems, may that be cataracts or the myopic wave t
- National Cancer Institute Director Ned Sharpless to Become Acting FDA Headhttps://modernod.com/news/national-cancer-institute-director-ned-sharpless-to-cecome-acting-fda-head/2476373/Ned Sharpless, MD, the current director of the US National Cancer Institute (NCI), will assume the position of acting chief of the FDA when Scott Gottlieb, MD, steps down next month. Dr. Gottlieb, who recently tendered his resignation from the role, is said to have recommended Dr. Sharpless for t
- Gottlieb’s Quick Goodbye Triggers Investor Panic, Biopharma Bewildermenthttps://modernod.com/news/gottliebs-quick-goodbye-triggers-investor-panic-biopharma-bewilderment/2476360/When FDA Commissioner Scott Gottlieb got his job, critics called him a shill and industry types figured they’d gained a friend in the most important drug regulatory agency in the world. It didn’t turn out quite that way. Gottlieb was biopharma-friendly—to the point where the Na
- Unum Poll Finds 40 Percent of Adults Spend 12+ Hours on Devices Each Dayhttps://modernod.com/news/unum-poll-finds-40-percent-of-adults-spend-12-hours-on-devices-each-day/2476235/It’s the time of year when many Americans resolve to eat healthier, get more exercise or save more money. But a new resolution in this digital-crazed culture should be to give your eyes a break from too much screen time. A recent poll by employee benefits company Unum found that 40 percent of U.S
- Johnson & Johnson Vision Launches MyAcuvue Subscription Programhttps://modernod.com/news/johnson-johnson-vision-launches-myacuvue-subscription-program/2479759/Johnson & Johnson Vision announced the launch of its MyAcuvue Subscription Program, developed to provide contact lens wearers greater access and convenience when purchasing an annual supply of Acuvue Brand contact lenses through their eye care professional. “We continue to look for way
- Silgan Dispensing Introduces Iridya Eye Dropper to Ensure Accurate Doses Down to the Drophttps://modernod.com/news/silgan-dispensing-introduces-iridya-eye-dropper-to-ensure-accurate-doses-down-to-the-drop/2479804/Silgan Dispensing has launched Iridya, a next-generation, multi-dose preservative-free eye dropper. The Iridya eye dropper ensures consumers an accurate dose and an easy-to-use design, while also providing safe delivery of ophthalmic medication. Its elongated tip provides greater accuracy when di
- Visulytix’s AI Tool Equivalent to Human Experts in Glaucoma Detectionhttps://modernod.com/news/visulytixs-ai-tool-equivalent-to-human-experts-in-glaucoma-detection/2480181/Visulytix announced that Pegasus-disc, its artificial intelligence (AI) decision support tool for the analysis of retinal images, has been shown to perform similarly to the consensus opinion of human experts when detecting glaucoma from optic disc images. This follows a study conducted on the ima
- Becton, Dickinson and Company Names Peter Menziuso EVP and President, BD Interventionalhttps://modernod.com/news/becton-dickinson-and-company-names-peter-menziuso-evp-and-president-bd-interventional/2487145/BD (Becton, Dickinson and Company), a global medical technology company, announced that Peter Menziuso has been named executive vice president and president, BD Interventional, effective June 1. Mr. Menziuso spent more than 30
- Wayne Caulder Joins Bausch + Lomb as Vice President and General Manager, Surgical, UShttps://modernod.com/news/wayne-caulder-joins-bausch-lomb-as-vice-president-and-general-manager-surgical-us/2482881/Wayne Caulder has joined Bausch + Lomb as vice president and general manager, Surgical, US and Canada. Mr. Caulder brings more than 30 years of experience in the eye health industry across multiple therapeutic categories, including cataract and refractive surgery, retina and r
- Hoya Launches VisuPro Advanced Focus Spectacle Lenses for Patients Experiencing Early Symptoms of Presbyopiahttps://modernod.com/news/hoya-launches-visupro-advanced-focus-spectacle-lenses-for-patients-experiencing-first-symptoms-of-presbyopia/2482724/Hoya has launched its VisuPro All Day and VisuPro Flex advanced focus spectacle lenses, which are designed to help people in their late 30s to mid-40s that are beginning to experience presbyopia. As people enter this age group, they may begi